FI69450C - Foerfarande foer framstaellning av nya som immunstimulanter anaendbara di-o-n-alkylglycerolderivat - Google Patents

Foerfarande foer framstaellning av nya som immunstimulanter anaendbara di-o-n-alkylglycerolderivat Download PDF

Info

Publication number
FI69450C
FI69450C FI791531A FI791531A FI69450C FI 69450 C FI69450 C FI 69450C FI 791531 A FI791531 A FI 791531A FI 791531 A FI791531 A FI 791531A FI 69450 C FI69450 C FI 69450C
Authority
FI
Finland
Prior art keywords
compounds
immunstimulanter
anaendbara
alkylglycerolderivat
nya
Prior art date
Application number
FI791531A
Other languages
English (en)
Finnish (fi)
Other versions
FI69450B (fi
FI791531A (fi
Inventor
Allen Richard Kraska
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI791531A publication Critical patent/FI791531A/fi
Application granted granted Critical
Publication of FI69450B publication Critical patent/FI69450B/fi
Publication of FI69450C publication Critical patent/FI69450C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/44—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reduction and hydrolysis of nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI791531A 1978-05-15 1979-05-14 Foerfarande foer framstaellning av nya som immunstimulanter anaendbara di-o-n-alkylglycerolderivat FI69450C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/906,260 US4173641A (en) 1978-05-15 1978-05-15 Di-O-n-alkyl glycerol derivatives as immune stimulants
US90626078 1978-05-15

Publications (3)

Publication Number Publication Date
FI791531A FI791531A (fi) 1979-11-16
FI69450B FI69450B (fi) 1985-10-31
FI69450C true FI69450C (fi) 1986-02-10

Family

ID=25422164

Family Applications (1)

Application Number Title Priority Date Filing Date
FI791531A FI69450C (fi) 1978-05-15 1979-05-14 Foerfarande foer framstaellning av nya som immunstimulanter anaendbara di-o-n-alkylglycerolderivat

Country Status (38)

Country Link
US (1) US4173641A (nl)
JP (2) JPS5924974B2 (nl)
AR (1) AR221724A1 (nl)
AT (1) AT372678B (nl)
AU (1) AU513771B2 (nl)
BE (1) BE876229A (nl)
CA (1) CA1105935A (nl)
CH (1) CH639939A5 (nl)
DD (1) DD144540A5 (nl)
DE (1) DE2919514C2 (nl)
DK (1) DK149946C (nl)
EG (1) EG15252A (nl)
ES (1) ES480565A1 (nl)
FI (1) FI69450C (nl)
FR (1) FR2426039A1 (nl)
GB (1) GB2021580B (nl)
GR (1) GR72419B (nl)
GT (1) GT197957869A (nl)
HK (1) HK13584A (nl)
HU (1) HU180283B (nl)
IE (1) IE48229B1 (nl)
IL (1) IL57268A (nl)
IN (1) IN150574B (nl)
IT (1) IT1115217B (nl)
KE (1) KE3354A (nl)
LU (1) LU81253A1 (nl)
MY (1) MY8500096A (nl)
NL (1) NL175524C (nl)
NO (1) NO151285C (nl)
NZ (1) NZ190444A (nl)
PH (1) PH15256A (nl)
PL (1) PL123910B1 (nl)
PT (1) PT69607A (nl)
SE (1) SE429966B (nl)
SG (1) SG65483G (nl)
SU (1) SU1122220A3 (nl)
YU (1) YU41156B (nl)
ZA (1) ZA792306B (nl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255426A (en) * 1979-07-09 1981-03-10 Pfizer Inc. 1-(2-Hydroxy-3-n-alkoxypropyl)-4-substituted-piperazines and piperidines
US4312877A (en) * 1979-07-09 1982-01-26 Pfizer Inc. 1-(2-Hydroxy-3-n-alkoxypropyl)-4-substituted piperidines, pharmaceutical compositions, thereof and use thereof
US4310550A (en) * 1979-10-26 1982-01-12 Pfizer Inc. Lipid amines formulated with fat or lipid emulsions as vaccine adjuvants
US4395394A (en) * 1979-10-26 1983-07-26 Pfizer Inc. Use of lipid amines formulated with fat or lipid emulsions as vaccine adjuvants
JPS60105650A (ja) * 1983-11-14 1985-06-11 Ono Pharmaceut Co Ltd グリセリン誘導体、その製造方法及びその誘導体を含有する薬剤
US4880626A (en) * 1985-01-18 1989-11-14 Mcmichael John Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome
JPS62156230A (ja) * 1985-12-27 1987-07-11 Nippon Steel Corp 帯状物の蛇行修正方法
US4842862A (en) * 1986-07-03 1989-06-27 International Minerals & Chemical Corp. Immunostimulating agents
ZA899436B (en) * 1988-12-12 1990-08-29 Ciba Geigy Piperidine derivatives
WO2005077963A1 (fr) * 2004-01-16 2005-08-25 Institut Superieur Agricole De Beauvais DErivEs de saccharides et d'itols possEdant un groupement O-alkyle ou un groupement O-alkyle et un groupement O-n-butanoyle. Applications comme mEdicaments dans les pathologies prolifEratives tumorales ou bEnignes.
WO2011076807A2 (en) 2009-12-23 2011-06-30 Novartis Ag Lipids, lipid compositions, and methods of using them

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2738351A (en) * 1952-08-02 1956-03-13 Bristol Lab Inc Substituted glycerol ethers
US3432602A (en) * 1967-12-20 1969-03-11 Astra Ab Oral alkyl glycerol ether improvement in radiation,radiomimetic,or cytostatic tumor therapies
US3943173A (en) * 1972-11-22 1976-03-09 Smithkline Corporation 3-Alkylamino- alpha-aminomethyl-4-hydroxybenzyl alcohols
US4012528A (en) * 1974-06-03 1977-03-15 Smithkline Corporation α-AMINOALKYL-3-(1,2-DIHYDROXYETHYL)-4-HYDROXY-BENZYL ALCOHOLS HAVING β-ADRENERGIC STIMULANT ACTIVITY
US4069223A (en) * 1977-05-02 1978-01-17 G. D. Searle & Co. 4-Aminomethyl-1-(3,3,3-triarylpropyl)-4-arylpiperidine and derivatives thereof
US4166132A (en) * 1977-08-18 1979-08-28 Pfizer Inc. Antiviral amine derivatives of glycerol and propanediols

Also Published As

Publication number Publication date
DD144540A5 (de) 1980-10-22
NO791604L (no) 1979-11-16
PH15256A (en) 1982-11-02
IT1115217B (it) 1986-02-03
AU4701679A (en) 1979-11-22
NL175524C (nl) 1984-11-16
CH639939A5 (fr) 1983-12-15
GT197957869A (es) 1980-11-04
PT69607A (en) 1979-06-01
DE2919514C2 (de) 1982-06-03
SE7904216L (sv) 1979-11-16
AT372678B (de) 1983-11-10
JPS5924974B2 (ja) 1984-06-13
BE876229A (fr) 1979-11-14
US4173641A (en) 1979-11-06
CA1105935A (en) 1981-07-28
MY8500096A (en) 1985-12-31
JPS58131947A (ja) 1983-08-06
SG65483G (en) 1984-07-27
YU41156B (en) 1986-12-31
HK13584A (en) 1984-02-24
ATA356179A (de) 1983-03-15
FR2426039B1 (nl) 1983-12-16
IE48229B1 (en) 1984-11-14
HU180283B (en) 1983-02-28
NZ190444A (en) 1981-05-29
DE2919514A1 (de) 1979-11-22
AR221724A1 (es) 1981-03-13
GB2021580B (en) 1982-09-08
LU81253A1 (fr) 1979-12-07
ZA792306B (en) 1980-05-28
GR72419B (nl) 1983-11-03
ES480565A1 (es) 1980-08-16
FR2426039A1 (fr) 1979-12-14
IN150574B (nl) 1982-11-13
GB2021580A (en) 1979-12-05
NO151285B (no) 1984-12-03
NO151285C (no) 1985-03-13
IE790938L (en) 1979-11-15
IL57268A0 (en) 1979-09-30
KE3354A (en) 1983-12-16
IL57268A (en) 1982-05-31
PL123910B1 (en) 1982-12-31
JPS6139301B2 (nl) 1986-09-03
AU513771B2 (en) 1980-12-18
PL215573A1 (nl) 1980-07-01
YU109479A (en) 1983-02-28
DK149946C (da) 1987-06-15
FI69450B (fi) 1985-10-31
NL7903769A (nl) 1979-11-19
JPS55378A (en) 1980-01-05
FI791531A (fi) 1979-11-16
DK149946B (da) 1986-11-03
SU1122220A3 (ru) 1984-10-30
SE429966B (sv) 1983-10-10
IT7922664A0 (it) 1979-05-14
DK102479A (da) 1979-11-16
EG15252A (en) 1986-09-30

Similar Documents

Publication Publication Date Title
US11117919B2 (en) Icariside compound, preparation method thereof, and application thereof
EP0196415B1 (en) Trichostatins a and c as antitumour drugs
KR100263804B1 (ko) 백신 보강제
FI69450C (fi) Foerfarande foer framstaellning av nya som immunstimulanter anaendbara di-o-n-alkylglycerolderivat
NO154344B (no) Analogifremgangsmaate for fremstilling av antivirale amin- og amidin-derivater.
Kai et al. Studies on the immunopotentiating effects of a streptococcal preparation, OK-432. I. Enhancement of T cell-mediated immune responses of mice.
EP0684817A1 (en) Cancer treatment
WO1999051720A2 (en) Methods for production of therapeutic cytokines
EP0046713A1 (en) Fluorinated pentene diamine derivatives
US5674693A (en) Derivatives of 2-nitro-imidazoles as hypoxic cell markers
FI75802C (fi) Foerfarande foer framstaellning av saosom immunostimulerande aemnen anvaendbara bis- och polydisulfider.
RU2027434C1 (ru) Иммуномодулирующее средство
IT9048102A1 (it) Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono
WO2023160112A1 (zh) 嗜氮酮类化合物及其在制备抗肿瘤药物中的用途
EA009049B1 (ru) Четвертичные хелидониновые и алкалоидные производные, способ их получения и их применение в производстве лекарственных средств
CN112353809B (zh) 一种黄芪甲苷类化合物的药物用途
Lovett III et al. Suppressor cells and increased primary tumor growth rate induced by thiopental
US4696935A (en) Method of treating transplanted tumors and modulating the immune response
RU2045265C1 (ru) Иммунодепрессант
EP0273732A2 (en) Streptovaricin C derivatives as anti-AIDS virus agents
Gebel et al. In Vitro and In Vivo Studies of a 2, 4, 6-Trinitrophenyl {TNP)-Binding Immunoglobulin A (IgA) Lymphoma Isolated From MOPC-315, a TNP-Binding IgA Plasmacytoma of BALB/c Mice
Sava et al. Modification of the Growth of Mca Mammary-Carcinoma of Cba Mouse by New Adamantylpeptides
JPH072690A (ja) インターロイキン２を含有してなる免疫療法剤
JPS63201126A (ja) 免疫グロブリンｅに起因する疾患治療剤
HU195819B (en) Process for producing 2-furyl-butyrolactone derivatives and pharmaceutics comprising these compounds

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: PFIZER INC.